Testing effectiveness (Phase 2)Study completedNCT00077402
What this trial is testing
Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer
Who this might be right for
Prostate Cancer
Cancer Therapeutics Research Group 50